The Utility of Futility
Imaging the Clot
Endovascular Revascularization of Symptomatic Acute Extracranial Internal Carotid Artery Occlusion
From Case Study to Prospective Study
Possible Mechanistic Overlap Between Cavernous Malformations and Cerebral Developmental Venous Anomalies
A Systemic Review of the Risk Factors for Cervical Artery Dissection
Response: A Systemic Review of the Risk Factors for Cervical Artery Dissection
Transcranial Doppler and Carotid Artery Disease Strokes: More Than Just Risk Stratification
Response: Transcranial Doppler and Carotid Artery Disease Strokes: More Than Just Risk Stratification
Use of Quantitative Magnetic Resonance Angiography to Stratify Stroke Risk in Symptomatic Vertebrobasilar Disease
Response: Use of Quantitative Magnetic Resonance Angiography to Stratify Stroke Risk in Symptomatic Vertebrobasilar Disease
Should We Distinguish Between Periventricular and Deep White Matter Hyperintensities?
Response: Should We Distinguish Between Periventricular and Deep White Matter Hyperintensities?
HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcome
Response: HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcome
Is Neurointensive Care Really Optional for Comprehensive Stroke Care?
Evaluation of the Paraoxonases as Candidate Genes for Stroke
Heritability of the Function and Structure of the Arterial Wall
Heritability of Carotid Artery Distensibility in Hispanics
Time Trends of Ischemic Stroke Incidence and Mortality in Patients Diagnosed With First Atrial Fibrillation in 1980 to 2000
Overnight Changes in the Cerebral Vascular Response to Isocapnic Hypoxia and Hypercapnia in Healthy Humans
Absence of Microemboli on Transcranial Doppler Identifies Low-Risk Patients With Asymptomatic Carotid Stenosis
Significance of Susceptibility Vessel Sign on T2*-Weighted Gradient Echo Imaging for Identification of Stroke Subtypes
Shape and Volume of Lacunar Infarcts
Silent Cerebral Ischemia Detected With Diffusion-Weighted Imaging in Patients Treated With Protected and Unprotected Carotid Artery Stenting
Incidence of Recurrent Subarachnoid Hemorrhage After Clipping for Ruptured Intracranial Aneurysms
Revascularization End Points in Stroke Interventional Trials
Vitamin Intervention for Stroke Prevention Trial
Applying a Phase II Futility Study Design to Therapeutic Stroke Trials
Intravenous Heparin Started Within the First 3 Hours After Onset of Symptoms as a Treatment for Acute Nonlacunar Hemispheric Cerebral Infarctions
Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (≥80 Years) Stroke Patients
Emergent Stenting of Extracranial Internal Carotid Artery Occlusion in Acute Stroke Has a High Revascularization Rate
Determinants of Staged Endovascular and Surgical Treatment Outcome of Brain Arteriovenous Malformations
When a Parent Has a Stroke
In-Hospital Medical Complications and Long-Term Mortality After Ischemic Stroke
NIHSS Training and Certification Using a New Digital Video Disk Is Reliable
Variation in the Carotid Bifurcation Geometry of Young Versus Older Adults
Nedd9 Protein, a Cas-L Homologue, Is Upregulated After Transient Global Ischemia in Rats
Cerebral Blood Flow Thresholds for mRNA Synthesis After Focal Ischemia and the Effect of MK-801
Short-Term Administration of a New Free Radical Scavenger, Edaravone, Is More Effective Than its Long-Term Administration for the Treatment of Neonatal Hypoxic–Ischemic Encephalopathy
In Situ β-Irradiation of a Brain Arteriovenous Malformation Model
Cerebral Venous Malformations Have Distinct Genetic Origin From Cerebral Cavernous Malformations
Electrocardiographic Left Atrial Abnormalities and Risk of Ischemic Stroke
Apolipoprotein E Genotype and Incident Ischemic Stroke
Perfusion MRI Abnormalities in Speech or Motor Transient Ischemic Attack Patients
Reversal of Dense Signs Predicts Recovery in Acute Ischemic Stroke
Reliability and Validity of the Upper-Extremity Motor Activity Log-14 for Measuring Real-World Arm Use
Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
Thrombolysis Beyond the Guidelines
Low-Grade Carotid Stenosis
Supporting Family Caregivers in Stroke Care